NCT04472429 2025-11-03Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).Incyte CorporationPhase 3 Completed308 enrolled 17 charts 3 FDA